Barclays Betting on More JNJ Upside in 2020

Johnson & Johnson has been on a strong uptrend recently

Dec 19, 2019 at 9:26 AM
facebook twitter linkedin

Analysts' top 2020 picks are starting to roll in, and Barclays this morning mentioned Johnson & Johnson (NYSE:JNJ) as a stock that could be strong for bulls in the coming year. In a note, the brokerage firm wrote that the blue-chip drugmaker is still trading at a discount due to this year's litigation issues, and in response it upped its view to "overweight" from "equal weight" with a price target of $173, which is the highest of all covering analysts, according to Thomson Reuters' Eikon.

JNJ shares have already been in a sharp uptrend in recent weeks, really ever since they bounced from the $130 level in mid-November. By the numbers, the healthcare giant has gained 10% going back three months, outpacing the broader S&P 500 Index (SPX) during that time. The shares closed Wednesday at $143.19, just below their 52-week high of $144.98 from June.

Options traders have certainly been bullish. Data from the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) shows a 10-day call/put volume ratio of 3.88, which ranks in the 100th annual percentile, meaning there's been an extreme interest in long calls over puts.

During this two-week time frame, the biggest increases in open interest have occurred at the January 2020 145-strike call, along with the February 145 and 155 calls. Anyone who bought those contracts is betting on upside for Johnson & Johnson to start the new year. It's certainly not a bad time to buy premium on JNJ, based on the Schaeffer's Volatility Index (SVI) of 14%, a reading that's in the low 5th annual percentile.


Now is the time to join our thriving community of Event Traders who consistently profit from every earnings season. With this discounted subscription opportunity, you'll stay ahead of the curve and seize opportunities others miss. Do not let Q3 earnings season pass you by – subscribe now and supercharge your portfolio with expert insights that turn market reactions into profit-generating opportunities!! Don't waste another second... join us right now before the next trade targeting +200% is released!